ABIVAX Société Anonyme (EPA:ABVX)
France · Delayed Price · Currency is EUR 99.75
-3.55 (-3.44%)
Aug 20, 2026, 4:36 PM CET
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of €8.9 billion as of August 20, 2026. Its market cap has increased by 97.36% in one year.
Market Cap
8.90B
Enterprise Value
8.45B
Revenue
4.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
€99.75
ChartMarket Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 202.12M to 8.90B, an increase of 4,305.51%. That is a compound annual growth rate of 40.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 8.90B | -4.98% |
| Dec 31, 2025 | 9.37B | 2,088.64% |
| Dec 31, 2024 | 428.15M | -30.40% |
| Dec 29, 2023 | 615.18M | 493.46% |
| Dec 30, 2022 | 103.66M | -77.81% |
| Dec 31, 2021 | 467.16M | -1.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.79B |
| Inventiva | 925.04M |
| MedinCell | 879.83M |
| DBV Technologies | 760.50M |
| Genfit | 694.34M |
| Valneva SE | 582.60M |
| Valerio Therapeutics Société anonyme | 394.06M |
| Transgene | 199.66M |